Study Using CP-751,871 In Patients With Stage IV Colorectal Cancer That Has Not Responded To Previous Anti-Cancer Treatments
NCT00560560
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
168
Enrollment
INDUSTRY
Sponsor class
Conditions
Colorectal Neoplasm
Interventions
BIOLOGICAL:
CP-751, 871
Sponsor
Pfizer